Remedy (REMEDY) CMD 2024 summary
Event summary combining transcript, slides, and related documents.
CMD 2024 summary
9 Jul, 2026Strategic direction and future plans
Entering a new growth era in 2025, aiming for regular annual game launches and expansion of existing franchises into world-class entertainment properties, following years of transformation since 2016.
Four strategic pillars: grow world-class franchises, make distinctive category-leading games, enable successful productions, and self-publish owned games.
Focus on expanding Alan Wake and Control through sequels, spin-offs, and transmedia opportunities, leveraging a partnership with Annapurna for TV/film adaptations.
Max Payne Remake serves as a partner franchise project, balancing the portfolio and utilizing synergies.
Cancelled Vanguard project to focus resources on higher-potential titles and improve development velocity.
Financial guidance and targets
Target to double 2024 revenue by 2027, with continued growth beyond that milestone.
Aim for a 30% EBITDA margin by 2027 and to maintain that minimum level through 2030.
Minimum 100% return on investment per game, with business cases built for 3–5 year payback periods.
Self-publishing expected to significantly increase profit potential compared to previous publisher-funded models.
Funding secured through cash reserves, a €15 million convertible loan from Tencent, and improved cash position.
Business model and self-publishing transition
Transitioning from development fees and royalties to a revenue model dominated by self-published game sales.
Self-publishing enables greater financial upside, closer integration between development and publishing, and more direct audience engagement.
Publishing team expanded to over 18 people, with further selective hiring planned; operational scale achieved via key external partners.
Marketing budgets for AAA launches are managed carefully, with flexibility for post-launch investment, especially for multiplayer/service games.
Risks in self-publishing include marketing effectiveness and competition, mitigated by strong partnerships and systematic audience research.
Latest events from Remedy
- Profitable Q1 with strong game sales, CONTROL Resonant focus, and positive 2026 outlook.REMEDY
Q1 20265 May 2026 - 2025 revenue rose 17.5% to €59.5M, with CONTROL Resonant set for 2026 launch.REMEDY
Q4 202515 Apr 2026 - Revenue up 33.7%, Q2 up 16.2%, profitability improves, and key franchises advance.REMEDY
Q2 20241 Feb 2026 - Q3 2024 revenue up 129%, fueled by development fees, partnerships, and self-publishing shift.REMEDY
Q3 202417 Jan 2026 - Revenue up 49% in 2024; self-publishing and partnerships drive growth and profitability.REMEDY
Q4 20242 Dec 2025 - Revenue up 24.1%, profitability restored, and first self-published title launches in June.REMEDY
Q1 202528 Nov 2025 - Q2 revenue up 64% to EUR 16.9M; Firebreak launch underwhelms, but outlook stays positive.REMEDY
Q2 202523 Nov 2025 - Q3 revenue dropped 32% and a major impairment led to a sharp EBIT loss despite cash gains.REMEDY
Q3 202530 Oct 2025